Evotec SE
NASDAQ:EVO

  • LAST PRICE
    5.1000
  • TODAY'S CHANGE (%)
    0.5500 (12.0879%)
  • Bid / Lots
    5.5800/ 10
  • Ask / Lots
    5.6700/ 9
  • Open / Previous Close
    4.6100 / 4.5500
  • Day Range
    4.4900
    5.4200
  • 52 Week Range
    2.8500
    11.9999
  • Volume
    1,640,152

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

Charts

Price Comparison Graph. See accessible table below
Data delayed at least 15 minutes.

Biotechnology Industry Peers

CompanyMarket CapP/E Ratio (TTM)EPS Growth (5yr)
EVO
Evotec SE
1.6B
0.0x
---
As of 2024-11-15

Company Information

Evotec SE is a Germany-based drug discovery and development company. The company is engaged in development of new pharmaceutical products through research alliances and development partnerships with pharmaceutical and biotechnology companies, academic institutions, patient organizations and venture capital companies. The drug discovery solutions are provided in the form of fee-for-service work, integrated drug discovery alliances, development partnerships, licensing of drug candidates and consulting arrangements. Evotec SE operates in a number of areas, including neuroscience, diabetes and complications of diabetes, pain and inflammation, oncology, infectious diseases, respiratory diseases and fibrosis. Its pipeline covers a range of therapeutic areas, such as CNS Insomnia, Chronic cough, immunology & inflammation, women’s health endometriosis, nephrology, dermatological diseases, fibrotic disease and antiviral, among others.

Contact Information

Headquarters
Essener Bogen 7HAMBURG, Germany 22419
Phone
---
Fax
405-608-1222

Executives

Independent Chairwoman of the Supervisory Board
Iris Loew-Friedrich
Chief Executive Officer
Christian Wojczewski
Independent Vice Chairman of the Supervisory Board
Roland Sackers
Chief Financial Officer, Member of the Management Board
Laetitia Rouxel
Chief Operating Officer, Member of the Management Board
Craig Johnstone

Ratings

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

Reports

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals

Market Cap
$1.6B
Revenue (TTM)
---
Shares Outstanding
355.1M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
1.45
EPS
---
Book Value
---
P/E Ratio
0.0x
Price/Sales (TTM)
---
Price/Cash Flow (TTM)
---
Operating Margin
---
*GAAP = prior to non-GAAP analyst adjusted earnings.

Calendar

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.